Daily Stock Analysis, CSII, Cardiovascular Systems Inc, priceseries

Cardiovascular Systems Inc. Daily Stock Analysis
Stock Information
Open
29.50
Close
28.17
High
29.70
Low
28.06
Previous Close
29.19
Daily Price Gain
-1.02
YTD High
29.70
YTD High Date
Feb 21, 2017
YTD Low
23.28
YTD Low Date
Jan 9, 2017
YTD Price Change
4.06
YTD Gain
16.84%
52 Week High
29.70
52 Week High Date
Feb 21, 2017
52 Week Low
7.50
52 Week Low Date
Feb 24, 2016
52 Week Price Change
20.17
52 Week Gain
252.13%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 26. 2015
29.56
Feb 20. 2015
35.34
18 Trading Days
19.55%
Link
LONG
Jul 7. 2015
27.73
Jul 24. 2015
30.25
13 Trading Days
9.10%
Link
LONG
Mar 1. 2016
8.72
Mar 15. 2016
9.79
10 Trading Days
12.25%
Link
LONG
Mar 31. 2016
10.37
Apr 28. 2016
13.96
20 Trading Days
34.61%
Link
LONG
May 20. 2016
15.29
Jun 17. 2016
17.46
19 Trading Days
14.17%
Link
LONG
Aug 3. 2016
19.74
Sep 1. 2016
23.59
21 Trading Days
19.52%
Link
LONG
Nov 7. 2016
23.67
Nov 22. 2016
25.38
11 Trading Days
7.24%
Link
Company Information
Stock Symbol
CSII
Exchange
NasdaqGS
Company URL
http://www.csi360.com
Company Phone
651-259-1600
CEO
Scott R. Ward
Headquarters
Minnesota
Business Address
1225 OLD HWY 8 NW, ST. PAUL, MN 55112
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001180145
About

Cardiovascular Systems, Inc., a medical technology company, develops, manufactures, and markets devices to treat vascular diseases in the United States.

Description

Cardiovascular Systems, Inc., a medical technology company, develops, manufactures, and markets devices to treat vascular diseases in the United States. It offers peripheral arterial disease products, including Stealth 360° Peripheral Orbital Atherectomy System (OAS), Diamondback 360 Peripheral OAS, Diamondback 360 60cm Peripheral OAS access device, and the 4 Diamondback 360 French 1.25 Peripheral OAS access device products for treating a range of plaque types, such as calcified plaque, in leg arteries both above and below the knee and address many of the limitations associated with existing surgical, catheter, and pharmacological treatment alternatives, as well as Diamondback 360 Coronary OAS, a catheter-based platform to facilitate stent delivery in patients with coronary artery disease. The company sells its products directly to hospitals or office-based labs. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.